PROMETIC AND HEMATECH BIOTHERAPEUTICS CLOSE $10 MILLION ORPHAN DRUG LICENSE AND STRATEGIC MANUFACTURING DEAL

May 7, 2012
Posted by: Prometic Prometic
Posted In: Press Releases, Press Releases 2012
X